NCT00316628View on ClinicalTrials.gov

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

June 30, 2005

Conditions

Influenza

Interventions

BIOLOGICAL

influenza vaccine

Trial Locations (2)

66100

G. D'Annunzio University, Chieti

Unknown

Office of Hygiene and Public Health, ASL Lanciano, Lanciano

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY